The in-house legal team at Terumo Neuro has accumulated numerous wins over this past year. The 15-person team for the Aliso Viejo-based medical device maker in July won an injunction against three ...

Terumo Neuro's SOFIA ™ Catheter Line is Backed By 10 Years of Proven Clinical Performance1-9 and Innovation – The New SOFIA™ Flow 88 Offers Reliable Trackability, Proximal Stability and ...

MicroVention Terumo, owned by Japanese medical device maker Terumo Corp., is embarking on its long-term growth plan under a new name.The company, which is known for making products to treat strokes ...

ALISO VIEJO, Calif., March 19, 2025 /PRNewswire/ -- Terumo Neuro, a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, proudly marks the 15th ...

MicroVention, Inc., a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, today announced its official rebranding to Terumo Neuro, effective immediately ...

Terumo Neuro noted that the launch of the catheter builds on the SOFIA Catheter line legacy, which has been used in over 500,000 procedures in 170 nations over the last ten years.

About Terumo Neuro (Formerly MicroVention, Inc.) We are in business to create and deliver Game-changing Impact™—innovations that redefine what is possible in neuroendovascular treatment to ...

"Terumo Neuro's SOFIA 88 Neurovascular Support Catheter is truly one of the best products in this category, especially when using a short 8F sheath," said Dr. Ameer Hassan, Head of Neuroscience ...

Terumo Neuro's SOFIA ™ Catheter Line is Backed By 10 Years of Proven Clinical Performance and Innovation – The New SOFIA™ 88 Catheter Offers Reliable Trackability, Proximal Stability and ...

--Terumo Neuro, a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, today announced the commercial availability of the SOFIA™ 88 Neurovascular ...